Literature DB >> 6741634

Factors influencing the outcome in acute subdural haematoma. A review of 330 cases.

B Klun, M Fettich.   

Abstract

A series of 330 consecutive patients with acute subdural haematomas has been selected to analyze the clinical signs which influence the outcome. To assure a uniformity, the material dates from before the CT era. Four main factors have been selected: age, pupillary changes, dynamics of the clinical development, and the state of consciousness. The importance and the characteristics of different factors are discussed. A simple grading system, which was used as a prognostic orientation guide, is presented. Finally, some prognostic conclusions are made.

Entities:  

Mesh:

Year:  1984        PMID: 6741634     DOI: 10.1007/BF01401312

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Surgical management of acute subdural hematomas.

Authors:  A J van der Werf
Journal:  Clin Neurol Neurosurg       Date:  1975       Impact factor: 1.876

2.  Factors affecting survival from subdural hematoma.

Authors:  T Richards; J Hoff
Journal:  Surgery       Date:  1974-02       Impact factor: 3.982

3.  Surgically treated traumatic subdural hematomas.

Authors:  K G Jamieson; J D Yelland
Journal:  J Neurosurg       Date:  1972-08       Impact factor: 5.115

4.  Extradural and subdural hematomas. Changing patterns and requirements of treatment in Australia.

Authors:  K G Jamieson
Journal:  J Neurosurg       Date:  1970-12       Impact factor: 5.115

5.  [Modifications of the pupil in acute subdural hematoma].

Authors:  A B Safran; J Berney
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1977

6.  Contribution to the surgical treatment of acute supratentorial subdural haematomas.

Authors:  G P Cantore; R Delfini; L Neri
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  The outcome from acute subdural haematoma following decompressive hemicraniectomy.

Authors:  M Shigemori; K Syojima; K Nakayama; T Kojima; T Ogata; M Watanabe; S Kuramoto
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

8.  Acute subdural hematomas. Review of 144 cases.

Authors:  D A Fell; S Fitzgerald; R H Moiel; P Caram
Journal:  J Neurosurg       Date:  1975-01       Impact factor: 5.115

9.  Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours.

Authors:  J M Seelig; D P Becker; J D Miller; R P Greenberg; J D Ward; S C Choi
Journal:  N Engl J Med       Date:  1981-06-18       Impact factor: 91.245

10.  Outcome following acute subdural haematoma.

Authors:  J Hernesniemi
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

  10 in total
  6 in total

1.  "Benign" acute subdural haematomas. Analysis of 12 cases.

Authors:  E G Singounas; G Sfakianos; I Sourtzis; P C Karvounis
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Predictors for functional recovery and mortality of surgically treated traumatic acute subdural hematomas in 256 patients.

Authors:  Kyu-Hong Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

3.  [Causes of and circumstances in death due to subdural hematoma].

Authors:  F Mohsenian; K Lieske; K Haba; K Püschel
Journal:  Unfallchirurgie       Date:  1990-12

4.  One hundred and twenty-seven cases of acute subdural haematoma operated on. Correlation between CT scan findings and outcome.

Authors:  F Massaro; M Lanotte; G Faccani; C Triolo
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Acute subdural haematoma in adults: an analysis of outcome in comatose patients.

Authors:  Z Kotwica; J Brzeziński
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  The clinical relevance of ABO blood type in 100 patients with acute subdural hematoma.

Authors:  Daniel Dubinski; Sae-Yeon Won; Bedjan Behmanesh; Nina Brawanski; Christof Geisen; Volker Seifert; Christian Senft; Juergen Konczalla
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.